<bill session="116" type="s" number="3070" updated="2022-10-28T01:45:52Z">
  <state datetime="2019-12-17">REFERRED</state>
  <status>
    <introduced datetime="2019-12-17"/>
  </status>
  <introduced datetime="2019-12-17"/>
  <titles>
    <title type="display">Preventing Pill Mills Through Data Sharing Act</title>
    <title type="short" as="introduced">Preventing Pill Mills Through Data Sharing Act</title>
    <title type="official" as="introduced">A bill to modify reporting requirements under the Controlled Substances Act.</title>
  </titles>
  <sponsor bioguide_id="F000062"/>
  <cosponsors>
    <cosponsor bioguide_id="C001047" joined="2019-12-17"/>
    <cosponsor bioguide_id="D000563" joined="2019-12-17"/>
    <cosponsor bioguide_id="G000386" joined="2019-12-17"/>
  </cosponsors>
  <actions>
    <action datetime="2019-12-17">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-12-17" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
      <reference ref="CR S7116-7119" label="Sponsor introductory remarks on measure"/>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="8732" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Business records"/>
    <term name="Congressional oversight"/>
    <term name="Department of Justice"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Government information and archives"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2021-08-10T18:15:31Z" status="Introduced in Senate">Preventing Pill Mills Through Data Sharing Act

This bill expands reporting requirements concerning the sale, delivery, or disposal of controlled substances that apply to drug manufacturers and distributors, including by extending the requirements to pharmacies and increasing the frequency of the reporting.</summary>
</bill>
